Advertisement

Cerevel Therapeutics Holdings, Inc. CERE

Set alert

Price alert · CERE

All alert types
44.96 +44.96 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
8.19B
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-15.40
Beta
1.41
Short ratio
2.37
Inst. own
85.12%
Dividend
0.00
Ex-div date
Earnings
Aug 7, 2024
50-d avg
41.63
200-d avg
39.55
1y target
43.40

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for CERE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue → Gross Profit: $6.74MGross Profit → Expenses: $6.74MRevenue → Cost of Revenue: $1.50MExpenses → Selling, General & Admin: $40.93MExpenses → Research & Development: $97.13MExpenses → Other Expenses: $1.15MExpenses → Income Tax: $188.00KNet Loss → Expenses: $132.66MGross Profit$6.74MNet Loss$132.66MCost of Revenue$1.50MExpenses$139.40MSelling, General & Admin$40.93MResearch & Development$97.13MOther Expenses$1.15MIncome Tax$188.00KRevenue$8.25M

Period ending Mar 31, 2024 · select a line to chart its history

Income statement

CERE quarterly income statement
142.66M
106.42M
36.23M
-142.66M
2.65M
138.00K
-131.91M
-131.91M
-131.91M
-131.91M
-0.73
-0.73
-0.73
-129.12M
-129.12M
181.61M
181.61M

Balance sheet

CERE quarterly balance sheet
322.40M
322.40M
744.45M
525.86M
218.59M
859.58M
44.60M
1.13B
3.52M
482.30M
84.10M
478.78M
562.89M
-1.53B
-1.09M
564.46M
564.46M
267.77M
482.30M
478.78M
10.84M

Cash flow

CERE quarterly cash flow
1.54M
4.47M
-96.03M
-271.00K
4.47M
19.16M
19.44M
-119.67M
20.93M
Advertisement